Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Change in Receivables: 2018-2024

Historic Change in Receivables for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to -$1.7 million.

  • Milestone Pharmaceuticals' Change in Receivables rose 1076.32% to $447,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $755,000, marking a year-over-year increase of 886.46%. This contributed to the annual value of -$1.7 million for FY2024, which is 173.86% down from last year.
  • Per Milestone Pharmaceuticals' latest filing, its Change in Receivables stood at -$1.7 million for FY2024, which was down 173.86% from $2.3 million recorded in FY2023.
  • Milestone Pharmaceuticals' 5-year Change in Receivables high stood at $2.3 million for FY2023, and its period low was -$1.7 million during FY2024.
  • For the 3-year period, Milestone Pharmaceuticals' Change in Receivables averaged around $454,333, with its median value being $755,000 (2022).
  • In the last 5 years, Milestone Pharmaceuticals' Change in Receivables crashed by 174.29% in 2021 and then surged by 886.46% in 2022.
  • Yearly analysis of 5 years shows Milestone Pharmaceuticals' Change in Receivables stood at -$35,000 in 2020, then tumbled by 174.29% to -$96,000 in 2021, then soared by 886.46% to $755,000 in 2022, then spiked by 208.08% to $2.3 million in 2023, then slumped by 173.86% to -$1.7 million in 2024.